Trial intelligence / Profile preview

AZT in HIV Infection Post First Episode PCP

NCT00000700Phase 3Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of zidovudine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.

02

Drugs

zidovudine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00000700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000700.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call